Interact to see
Advertisement
Advertisement
ADNRX vs VMGIX
ADNRX vs VMGIX Comparison
Open Charts ADNRX vs VMGIX
American Beacon ARK Transfmt Innov R6
Price$20.68
Change+$0.12 (+0.58%)
VolumeN/A
Net Assets213.22M
Vanguard Mid-Cap Growth Index Investor
Price$111.58
Change-$0.39 (-0.35%)
VolumeN/A
Net Assets32.45B
ADNRX vs VMGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. VMGIX commentary
Aug 12, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and VMGIX is a Buy.
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 32.4B vs. ADNRX (213M). VMGIX pays higher dividends than ADNRX: VMGIX (0.51) vs ADNRX (0.00). ADNRX was incepted earlier than VMGIX: ADNRX (5 years) vs VMGIX (19 years). ADNRX (1.13) is less costly to investors than VMGIX (0.19). ADNRX is a more actively managed with annual turnover of: 38.00 vs. VMGIX (21.00). ADNRX has a lower initial minimum investment than VMGIX: ADNRX (0) vs VMGIX (3000). ADNRX annual gain was more profitable for investors over the last year : 81.24 vs. VMGIX (26.11).
| ADNRX | VMGIX | ADNRX / VMGIX | |
| Total Expense Ratio | 1.00 | 0.19 | 526% |
| Annual Report Gross Expense Ratio | 1.13 | 0.19 | 595% |
| Fund Existence | 5 years | 19 years | - |
| Gain YTD | 32.649 | 12.212 | 267% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 213M | 32.4B | 1% |
| Annual Yield % from dividends | 0.00 | 0.51 | - |
| Returns for 1 year | 81.24 | 26.11 | 311% |
| Returns for 3 years | 36.86 | 37.13 | 99% |
| Returns for 5 years | N/A | 59.92 | - |
| Returns for 10 years | N/A | 168.27 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement